Niranian Kanesa-thasan

Title: Niranian Kanesa-thasan: Innovator in Vaccine Development

Introduction

Niranian Kanesa-thasan is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of vaccine development, particularly in relation to the dengue virus. His work is characterized by a commitment to advancing public health through innovative solutions.

Latest Patents

Niranian holds 1 patent for his invention titled "Attenuated dengue-2 virus vaccine." This patent provides vaccine compositions of an attenuated dengue-2 virus, which is produced by serial passage in PDK cells. The invention also outlines methods for stimulating the immune system of an individual to induce protection against the dengue-2 virus through the administration of the attenuated virus.

Career Highlights

Niranian Kanesa-thasan is affiliated with the US Government as represented by the Secretary of the Army. His role within this organization underscores his dedication to research and development in the field of infectious diseases. His work has the potential to impact public health significantly.

Collaborations

Niranian has collaborated with esteemed colleagues, including Kenneth H Eckels and Joseph R Putnak. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in achieving innovative breakthroughs.

Conclusion

Niranian Kanesa-thasan's contributions to vaccine development, particularly through his patent on the attenuated dengue-2 virus vaccine, exemplify his commitment to advancing medical science. His work not only showcases his innovative spirit but also reflects the collaborative efforts necessary to tackle global health challenges.